CVS Health Corporation (NYSE:CVS) EVP Helena Foulkes sold 39,340 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $81.88, for a total value of $3,221,159.20. Following the completion of the sale, the executive vice president now owns 84,337 shares of the company’s stock, valued at $6,905,513.56. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Helena Foulkes also recently made the following trade(s):

  • On Monday, June 26th, Helena Foulkes sold 20,333 shares of CVS Health Corporation stock. The shares were sold at an average price of $80.00, for a total value of $1,626,640.00.

Shares of CVS Health Corporation (CVS) opened at 79.56 on Friday. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $90.85. The firm has a market cap of $80.88 billion, a price-to-earnings ratio of 15.85 and a beta of 0.92. The firm has a 50-day moving average price of $79.11 and a 200-day moving average price of $78.98.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. During the same quarter in the previous year, the business earned $1.32 earnings per share. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Analysts predict that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Monday, October 23rd. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: CVS Health Corporation (CVS) EVP Sells $3,221,159.20 in Stock” was originally published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.watchlistnews.com/insider-selling-cvs-health-corporation-cvs-evp-sells-3221159-20-in-stock/1579312.html.

A number of hedge funds have recently bought and sold shares of CVS. Fieldpoint Private Securities LLC boosted its position in shares of CVS Health Corporation by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,000 shares during the period. Mercer Capital Advisers Inc. purchased a new stake in shares of CVS Health Corporation in the first quarter worth about $118,000. MPS Loria Financial Planners LLC purchased a new stake in shares of CVS Health Corporation in the second quarter worth about $119,000. Gemmer Asset Management LLC boosted its position in shares of CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after buying an additional 200 shares during the period. Finally, TB Alternative Assets Ltd. purchased a new stake in shares of CVS Health Corporation in the second quarter worth about $121,000. 81.49% of the stock is owned by hedge funds and other institutional investors.

Several analysts have issued reports on CVS shares. ValuEngine cut CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Vetr cut CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $87.97 target price for the company. in a report on Monday, June 5th. Jefferies Group LLC restated a “hold” rating and issued a $82.00 target price on shares of CVS Health Corporation in a report on Friday, June 9th. Cowen and Company restated an “outperform” rating and issued a $86.00 target price on shares of CVS Health Corporation in a report on Tuesday, June 13th. Finally, Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have given a buy rating to the company. CVS Health Corporation currently has a consensus rating of “Buy” and an average price target of $90.58.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Insider Buying and Selling by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.